|
|
Title | Creator | Relation Is Part Of |
201 |
|
How to Distinguish Retinal Disorders from Causes of Optic Nerve Dysfunction? | Andrew G. Lee | NANOS 2013: Refining the Clinical Localization of Neuro-Ophthalmic Diagnoses: What Test is Best? |
202 |
|
A Practice Pathway for the Management of Gliomas of the Anterior Visual Pathway: An Evidence-Based Approach | Andrew G. Lee | NANOS 1999: Update - Neurocutaneous Syndromes |
203 |
|
Reversible Visual Loss Due to Suprasellar Pneumocephalus After Trans-sphenoidal Surgery | Andrew G. Lee | NANOS 2003: Poster Presentations |
204 |
|
Idiopathic Intracranial Hypertension (IIH): Medical Treatment | Andrew G. Lee | NANOS 2014: When Neurosurgery & Neuro-Ophthalmology Collide |
205 |
|
Bilateral Uveal Tumors: An Unusual Case | David W. Zauel | NANOS 1983: Scientific Platform Presentations (Session 3) |
206 |
|
Bilateral Optic Neuritis | David W. Zauel | NANOS 1982: Scientific Platform Presentations (Session 2) |
207 |
|
Pupil Sparing Third Nerve Palsy | David W. Zauel | NANOS 1985: Scientific Platform Presentation (Session 3) |
208 |
|
Bilateral Disc Edema Associated with Ulcerative Colitis and Vasculitis on Skin Biopsy | David W. Zauel | NANOS 1984: Platform Presentations (Session I) |
209 |
|
The Functional Eye Exam | David W. Zauel | NANOS 1981: Various Subjects Symposium |
210 |
|
MR Imaging of the Cavernous Sinus | Benjamin M. Frishberg | NANOS 1990: Cavernous Sinus Symposium |
211 |
|
Eye Pain: A Neurologic Perspective - Primary Headache Disorders | Benjamin M. Frishberg | NANOS 2014: Eye Pain in the Quiet Eye Symposium |
212 |
|
Eye Pain: A Neurologic Perspective - Primary Headache Disorders | Benjamin M. Frishberg | NANOS 2014: Eye Pain in the Quiet Eye Symposium |
213 |
|
Pattern Evoked Electroretinography in Selected Patients with Ocular Migraine | Warren L. Felton | NANOS 1991: Poster Presentations (Session 1) |
214 |
|
Dorsal Midbrain Syndrome in a Patient with the Acquired Immune Deficiency Syndrome | Warren L. Felton | NANOS 1993: Poster Presentations (Session 2) |
215 |
|
Manifestations of Neurosarcoidosis with Emphasis on the Orbits and Visual Pathways | Warren L. Felton | NANOS 1993: Poster Presentations (Session 1) |
216 |
|
High-Dose IV Pulse Steroid Therapy in Dysthyroid Optic Neuropathy | Warren L. Felton | NANOS 1989: Scientific Platform Presentations (Session 2) |
217 |
|
Diagnosis and Treatment of Visual Complications of AIDS | William R. Freeman | NANOS 1990: AIDS and Lyme Disease Symposium |
218 |
|
New Approaches to Ophthalmic Diseases in AIDS | William R. Freeman | NANOS 1990: AIDS and Lyme Disease Symposium |
219 |
|
Diagnosis & Treatment of Ophthalmic Complications of AIDS | William R. Freeman | 1990 NANOS: AIDS and Lyme Disease Update |
220 |
|
New Approaches to Ophthalmic Diseases in AIDS | William R. Freeman | 1990 NANOS: AIDS and Lyme Disease Update |
221 |
|
Do Retinal Microvascular Changes Improve TIA Risk Stratification Scores? ABCD2 vs. ABCDEye | Beau Bruce, MD, PhD | NANOS Annual Meeting 2022: Scientific Platform Session I |
222 |
|
Deep Learning Can Accurately Distinguish Between True Papilledema and Optic Disc Drusen on Fundus Photographs | Kanchalika Sathianvichitr, Raymond Najjar, Zhiqun Tang, Steffen Hamann, Clare Fraser, J. Alexander Fraser, Elisabeth Wibroe, Mung Yan Lin, Étienne Bénard-Séguin, Caroline Vasseneix, Makoto Nakamura, Takano Fumio, Janvier Ngoy Kilangalanga, Fiona Costello, Selvakumar Ambika, Catherine Vignal-Clerm... | NANOS Annual Meeting 2022: Scientific Platform Session I |
223 |
|
Double Vision, Double Again | Virender Sachdeva, MS, DNB | NANOS Annual Meeting 2022: Complex Cases in Pediatric Neuro-Ophthalmology: Avoiding Mimickers, Missteps, and Misdiagnosis |
224 |
|
Endovascular Treatments of Neuro-Ophthalmic Disorders | Marc Dinkin, MD | NANOS Annual Meeting 2022: Does My Patient Need Surgery/A Procedure? Indications, Outcomes, and More! |
225 |
|
Electric Fields Direct Full-Length Optic Nerve Regeneration and Partial Restoration of Visual Function | Micalla Peng, BS | NANOS Annual Meeting 2022: Scientific Platform III |